T/QGCML 2229-2023 Technical Specifications for Rapid Detection of Drug Residues in Aquatic Products
T/QGCML 2229-2023
Basic Information
Scope
Main technical content: This document specifies the terms and definitions, principles, reagents and materials, instrumentation and equipment, detection steps, detection limits, and other aspects of the rapid detection technology for drug residues in aquatic products. This document is applicable to the rapid detection of five chlorophenol sodium, diazepam, furantoin metabolites, furantoin metabolites, furantoin metabolites, furantoin metabolites, malachite green, latent malachite green, chloramphenicol, trimethoprim, tetracyclines (chloramphenicol, oxytetracycline, tetracycline, doxycycline), fluoroquinolones (enrofloxacin, norfloxacin, ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, nalidixic acid, sarafloxacin, difloxacin, pefloxacin, marbofloxacin, florfenicol, oxolinic acid, dafloxacin, cynarin, fluroxacin), sulfa drugs (sulfamethoxazole, sulfamethoxazole, sulfadimethoxine, sulfadoxine, sulfadimethoxine, sulfadimethoxine, sulfadiazine sodium, sulfachloropyridazine, sulfadiazine, sulfadiazine) in aquatic products, a total of 40 kinds of drug residues.